KURA Award Disclosure
Fulk Jennifer · SEC Form 4 · Filed Sep 10, 2026
Award
Calculated transaction value
$0
Fulk Jennifer Chief Financial Officer
KURA
Kura Oncology
KURA
Transaction date
Sep 8, 2026
Public filing date
Sep 10, 2026
Filing lag
Filed 2 days later
KURA daily price context
Close on/before transaction
$12.52
Sep 8, 2026
Close before public filing
$12.09
Sep 9, 2026
Return since public filing
-4.71%
Through Sep 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Option to purchase common stock on Common Stock
- Quantity / price
- 450,000 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001193125-26-387934
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Kura Oncology, Inc. KURA Current | Award | Sep 8, 2026 | $0 |